Thomas Pike to Join Labcorp As President And Chief Executive Officer Of Its Drug Development Clinical Development Business Unit
Labcorp (NYSE:LH), a leading global life sciences company, today announced that Thomas (Tom) Pike will join Labcorp as president and chief executive officer of its Drug Development Clinical Development business unit on